Categories: CancerNews

The Assistance Fund Opens New Program for Biliary Tract Cancer

Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Biliary Tract Cancer

ORLANDO, FL / ACCESSWIRE / July 31, 2023 / The Assistance Fund, an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs, today announced the launch of a new copay assistance program for people living with biliary tract cancer. The program is designed to help eligible individuals pay for their out-of-pocket medical expenses related to biliary tract cancer, such as copays, coinsurance, and deductibles.

Biliary tract cancers impact the gallbladder, bile ducts, and ampulla of Vater.[1] The cancers are difficult to diagnose; by the time symptoms like jaundice, fatigue, and belly pain appear, the cancer has advanced.

“Because reaching a diagnosis can be so difficult for people living with biliary tract cancers, ensuring their immediate access to the treatment is critical,” said Danielle Vizcaino, President and CEO at The Assistance Fund. “Our Biliary Tract Cancer Copay Assistance Program will remove the financial hurdles of this process for so many patients and their families and will allow them to focus on improving their health.”

“As a family member of someone who faced a biliary tract cancer diagnosis, I am intimately familiar with how daunting the journey is to finding the right treatment and navigating access to it,” said Stacie Lindsey, Founder & CEO of the Cholangiocarcinoma Foundation. “With the launch of its Biliary Tract Cancer Copay Assistance Program, The Assistance Fund has forged a path for hundreds of patients to get the treatment they need and the improved quality of life it will bring.”

To learn more or determine eligibility for financial support, visit tafcares.org or call (855) 309-5525 to speak with a Patient Advocate.

A list of all the disease programs available from The Assistance Fund can be found on the website tafcares.org.

About The Assistance Fund

The Assistance Fund (TAF) is an independent charitable patient assistance organization that helps patients and families facing high medical out-of-pocket costs by providing financial assistance for their copayments, coinsurance, deductibles, and other health-related expenses. The Assistance Fund currently manages nearly 90 disease programs, each of which covers all the FDA-approved medications that treat a specific disease named in the disease program. Since its founding in 2009, TAF has helped nearly 180,000 children and adults access the treatment they need to stay healthy or manage a life-threatening, chronic, or rare disease. To learn more about The Assistance Fund, or for information on how to donate, please visit tafcares.org.

Media Contact

Margaret Figley

Senior Director of Communications

margaret.figley@tafcares.org

[1] Mayo Clinic, “What is biliary tract cancer?,” https://www.mayoclinic.org/diseases-conditions/cholangiocarcinoma/in-depth/what-is-biliary-tract-cancer/art-20544661, accessed May 2023.

Contact Information

Margaret Figley
Senior Director of Communications
margaret.figley@tafcares.org

SOURCE: The Assistance Fund (TAF)

View source version on accesswire.com:
https://www.accesswire.com/769177/The-Assistance-Fund-Opens-New-Program-for-Biliary-Tract-Cancer

Staff

Recent Posts

UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026

CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…

6 hours ago

Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…

9 hours ago

GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained

Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…

9 hours ago

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…

9 hours ago

Best Peptides for Anti-Aging: NAD+ Delivery Methods Compared as Telehealth Platforms Expand Access (2026 Analysis)

Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…

9 hours ago